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Abstract
Introduction: Data on the thyroid function of a randomly chosen elderly population was collected during a multicentre study performed 
in Poland (PolSenior) in 2007–2010. 
Material and methods: The population of 4,190 participants under study was divided into six age subgroups of > 65 to > 90 years of age 
and a younger group aged between 55 and 59 years. Assessment of thyroid function was based on hormonal measurements. 
Results: Concentrations of both TSH and fT4 were significantly higher in females than in males. No differences in TSH and fT4 concentrations 
between different age groups were found. Thyroid dysfunction was revealed in more than10% of participants, hypothyroidism in 7.95%, and 
hyperthyroidism in 2.95%. Both types of dysfunction were more prevalent in women, and in more than 80% both dysfunctions were subclinical.
In 1,542 participants, concentrations of TPOAb were measured. Increased TPOAb was revealed in 19% of the cohort and the prevalence 
of thyroid autoimmunity was higher in women and also more often found in participants with hypothyroidism. 
Conclusions: Cross sectional survey  revealed thyroid dysfunctions in over 10% of non selected elderly population. No age related differ-
ences were found in TSH concentrations, TPOAb positivity and prevalence of thyroid dysfunctions. (Endokrynol Pol 2012; 63 (5): 346–355)
Key words: elderly population, thyroid dysfunctions, hypothyroidism, hyperthyroidism, thyroid hormones, thyrotropin, anti thyroid peroxidase 
antibodies, thyroid autoimmunity, gender differences 
Streszczenie
Wstęp: Podczas wieloośrodkowego badania przeprowadzonego Polsce w latach 2007–2010 (PolSenior) zgromadzono dane dotyczące 
czynności tarczycy w wybranej losowo populacji w podeszłym wieku. 
Materiał i metody: Grupa badana licząca 4190 uczestników została podzielona na sześć podgrup w wieku od > 65 lat do > 90 i jedną pod-
grupę młodszych uczestników między 55. a 59. rokiem życia. Czynność tarczyc określano na podstawie wyników oznaczeń hormonalnych. 
Wyniki: Stężenia TSH i fT4 były znamiennie wyższe u kobiet niż u mężczyzn. Nie wykazano różnic w stężeniach obydwu tych hormonów 
między grupami wiekowymi. Zaburzenia czynności tarczycy stwierdzono u ponad 10% badanych, niedoczynność u 7, 95%, a nadczyn-
ność — u 2,95%. Obydwa typy dysfunkcji były częstsze u kobiet. W ponad 80% zaburzenia czynności tarczyc miały charakter utajony.
U 1542 uczestników oznaczono stężenia TPOAb. Podwyższone wartości — marker autoimmunologicznej choroby tarczycy stwierdzono 
u 19% tej populacji. Podwyższone TPOAb stwierdzano częściej u kobiet niż u mężczyzn, najczęściej w grupie osób z hipotyreozą. 
Wnioski: Zaburzenia czynności tarczycy stwierdzono u 10% losowo wybranych osób w podeszłym wieku. Nie stwierdzono zależnych od 
wieku różnic w stężeniach TSH ani w częstości występowania przeciwciał TPOAb i dysfunkcji tarczycy. (Endokrynol Pol 2012; 63 (5): 346–355)
Słowa kluczowe: populacja w podeszłym wieku, dysfunkcje tarczycy, niedoczynność tarczycy, nadczynność tarczycy, hormony tarczycy, hormon 
tyreotropowy, przeciwciała przeciwko peroksydazie tarczycowej, autoimmunologiczna choroba tarczycy, różnice zależne od płci
Implemented under the publicly-funded project No. PBZ-MEIN- 9/2/2006, Ministry of Science and Higher Education.
Introduction
Thyroid diseases are the commonest endocrine dis-
orders and their prevalence increases with ageing. 
Thyroid dysfunctions are about twice as frequent in 
the elderly compared to younger age groups. Accord-
ing to the previously published epidemiological data 
from different countries, overt and subclinical hypo-
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thyroidism was found in 0.5 to 15% of the population 
while overt and subclinical hyperthyroidism in 0.5 
to 8% of the population [1–5]. Greater prevalence in 
women was a constant finding. Autoimmune thyroid 
disease is the leading aetiological factor of endog-
enous thyroid failure. Earlier data from different 
countries and populations has produced divergent 
findings concerning the epidemiology of thyroid 
diseases and dysfunctions [6].
Another common cause of thyroid disorders world-
wide is iodine deficiency. Poland had been a country of 
mild or moderate iodine deficiency for several decades. 
In 1997, obligatory salt iodisation was reintroduced in 
Poland, so our country is now iodine sufficient. This 
change of iodine status might influence the epidemiol-
ogy of thyroid diseases in Poland. The measurable effect 
of obligatory salt fortification in our country was the 
reduced occurrence of goitre in children and pregnant 
women, and of neonatal hypothyroidism. 
 Previous observations in different populations have 
documented the transient increase of thyroid antibod-
ies positivity and iodine induced thyroid dysfunctions 
in the adult population after an increase of iodine 
supplementation, although discordant data has been 
presented [5–8].
There has been no previous nationwide study 
on the epidemiology of thyroid disorders in a Pol-
ish population. The present study was focused on 
elderly subjects.
This paper presents the results of PolSenior, a public-
ly funded research project designed to describe several 
aspects of life of a non selected population aged over 
65. Multidimensional data concerning many aspects of 
socioeconomic as well as general health data of an age-
ing population was collected. All participants were in-
terviewed and examined in their homes. Trained nurses 
collected information from the respondents [9, 10].
Thyroid function assessment in a representative age-
ing population was part of this multicentre nationwide 
project. Some of the data was published before the end 
of the project [10]. 
Material and methods
The cohort of 5,695 subjects from the randomly chosen, 
unselected population consented to take part in the study. 
Participants were between 65 and 90-plus years of age; the 
reference group was younger, between 55 and 59. They 
lived in urban, rural and mixed urban–rural areas in nine 
of Poland’s 16 provinces.  
In 4,190 participants, thyroid data was eligible and 
this group is described in this paper. The elderly cohort 
was divided into six age groups ranging from > 65 to 
> 90 years of age. The reference group consisted of 
subjects 55–59 years old. The number of participants in 
age groups was comparable. The population consisted 
of 50.8% males and 49.2% females. The distribution of 
sexes in most groups was nearly equal. The study was 
cross-sectional, and held between the years 2007–2010. 
The methodology has been described in earlier publica-
tions [9, 10 ]. 
The distribution of age, sex, and types of places of 
dwelling of the study group are presented in Tables I and II. 
The study involved the social, economic, psycho-
logical and health related aspects of the life of elderly 
people in several regions of Poland. Thyroid function 
was assessed based upon the results of TSH measure-
ments. In the majority of subjects, free thyroxine con-
centrations in serum were also measured. Because of 
the very wide range of aspects concerning living and 
health status investigated in the project, clinical data 
concerning thyroid status was scarce. Nevertheless, 
information concerning thyroid medication use and 
iodine rich preparations was available.
Table I. Age and sex distribution in the study group
Tabela I. Rozkład wieku i płci w badanej populacji
Age group) Women Men All
(years n  % n  % n %
55–59 314  55.6 251  44.4 565 13.5
65–69 318 51.2 294 48.04 612 14.6
70–74 344 49.6 350 50.4 694 16.6
75–79 291 46.04 341 53.9 632 15.1
80–84 258 46.04 302 53.9 560 13.6
85–89 270 43.9 345 56.1 625 14.5
≥ 90 260 50.7 253 49.3 513 16.65
All 2,055 49.05 2,135 50.95 4,190 100
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Respondents were interviewed and examined in 
their homes. Samples of venous blood were transported 
in vacuum containers and transferred to a local labora-
tory within two hours. After centrifugation, samples 
of serum were frozen and stored at –80oC and then 
delivered to the Central Laboratory where measure-
ments were performed. 
Thyrotropin concentration was measured by IRMA 
(Immunotech, Czech Republic). In this method, the 
reference values were 0.2–4.5 mIU/L; free thyroxine 
with RIA (Siemens US), reference values were 10.3–25.7 
pmol/L. Measurements were carried out with a gamma 
scintillation counter Wizard 1470. Thyroid status was 
defined based upon the results of thyrotropin (TSH) 
and free thyroxine (fT4) concentrations in the serum.
Stages of thyroid function were defined on the 
basis of TSH results. Participants with a TSH value of 
< 0.2 mIU/L were defined as the hyperthyroid group, 
> 4.5 as hypothyroid, and those with TSH between 
0.2 and 4.5 mIU/L were considered euthyroid. 
Aiming at estimation of the prevalence of auto-
immune thyroid disease in this elderly population, 
the presence of thyroid antiperoxidase antibodies 
(TPOAb) was measured. TPOAb was measured us-
ing RIA (Immunotech, Czech Republic); according to 
the reference data, results between 0 and 20 IU/L are 
defined as normal and values exceeding 20 IU/L are 
abnormal and suggest the presence of autoimmune 
thyroid disease. 
Statistical analysis of data was performed using 
Statistica 9.2 program, and Kruskal Wallis and U Mann 
Whitney tests were used for comparisons. 
Results
Hormone assays
TSH was measured in 4,051 blood samples. Arithmetical 
mean of TSH in the population was 2.55 ± 6.7 mIU/L 
and median 1.6 mIU/L. There were gender specific dif-
ferences in the TSH concentrations. Mean TSH in women 
was 2.9 ± 8.6 mIU/L and was significantly higher than in 
male subjects, where it was 2.2 ± 4.6 mIU/L (p = 0.01). 
Median values were higher in women (1.7 v. 1.55 mIU/L. 
The distribution of TSH in the whole population was 
not normal; there was a slight shift of the curve to the 
right (Fig. 1).
Mean concentration of free thyroxine in the whole 
population under study was 16.8 ± 8.5 pmol/L with 
median value 16.4 pmol/L. Gender dependent differ-
ences in free thyroxine concentrations were present. 
In women, mean fT4 was higher than in males: respec-
tively 17.1 ± 11.5 pmol/L v. 16.5 ± 3.6 pmol/L (p = 0.01). 
Median values of fT4 were 16.5 pmol/L in females and 
16.2 pmol/L in males.
Concentrations of TSH and fT4 in age groups are 
presented on Figures 2 and 3.
No significant differences were found in the concen-
trations of TSH and fT4 between the six age subgroups 
above 65 years. The values in TSH and fT4 between the 
younger group (55–59 years) and above 65 years group 
did not differ significantly. 
Concentrations of TSH and free thyroxine in serum 
were significantly negatively correlated: r = –0.3066, 
p = 0.000) in the whole group. Correlation was weaker 
in the younger population 55–59 years of age r = 
= –0.1668, p = 0.0240 than in the older group > 65 years 
of age: r = –0.3249, p = 0.000. 
Thyroid dysfunctions
According to the defined TSH criteria, 7.9% of re-
spondents from the whole cohort were classified 
as hypothyroid, 2.9% as hyperthyroid, and 89.1% 
were euthyroid (Tab. III). Hypothyroidism was more 
prevalent then hyperthyroidism and the incidence of 
thyroid dysfunctions was greater in women (13.87% 
v. 8.01%). 
In most respondents, thyroid dysfunctions were 
subclinical. In participants with thyroid dysfunctions, 
thyroid failure was overt in only 11% and hyperthyroid-
ism in about 20%. 
Table II. Dwelling places of residence of the PolSenior study participants whose TSH and thyroxine were measured 
Tabela II. Miejsca zamieszkania uczestników badania PolSenior , u których oceniono czynność tarczycy
Sex Towns — number of inhabitants (thousands) Villages All
< 20 > 20–50 > 50–200 > 200–500 > 500 N %
Males n 293 270 316 108     308 840 2055
% 6,68 5,39 6,42 2,43 8,02 20,10 49,05
Females n 280 226 269 102 336 842 2135
% 6,68 5,39 6,42% 2,43 8,02 20,10 50,95
Both sexes n 573 496 585 210 644 1682 4190
% 13,68 11,84 13,96 5,0  15,37 40,14 100
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Figure 1. TSH distribution in an elderly Polish population (n = 4,051)
Rycina 1. Rozkład wartości TSH w populacji ludzi starszych (n = 4051)
Figure 2. TSH in age groups of elderly population (n = 4,051)
Rycina 2. Rozkład wartości TSH w grupach wiekowych (n = 4051)
Figure 3. Free thyroxine in age groups of elderly population (n = 4,154)
Rycina 3. Rozkład wartości wolnej tyroksyny w grupach 
wiekowych (n = 4154)
Table III. Thyroid dysfunctions in relation to gender (n = 4,051)
Tabela III. Zaburzenia czynności tarczycy w zależności od płci (n = 4051)
Thyroid function Euthyroid Hyperthyroid Hypothyroid Number of subjects 
Whole cohort Number 3,610 119 322 4,051
% 89.11 2.94 7.95
Females Number 1,715 70 206 1,991
% 86.13 3.52 10.35
Males Number 1,895 49 116 2,060
% 91.99 2.38 5.63
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Occurrence of abnormal thyroid function did not 
change significantly with increasing age. There was 
a tendency towards a greater prevalence of advanced 
thyroid dysfunctions in the oldest. In the group aged 
> 90 years, hyperthyroidism occurred in 4.85% and hypo-
thyroidism in 9.7%. In the youngest subjects, 55–59 years 
old, the prevalence of hyperthyroidism was lowest: 
1.8% v. 2.94% in theelderly. These differences between 
subgroups had no statistical significance (Table IV). 
Thyroid medications
 In 4,126 respondents, data concerning both thyroid 
function and medication was available. 186 subjects, 
about 4.5% of the cohort, were on thyroid medications. 
Among 441 subjects with abnormal thyroid function, 
about 42% were treated with thyroxin or antithyroid 
medications. This means that less than half of the pa-
tients with thyroid dysfunctions were being treated. 
Nevertheless, it has to be stressed that 88% of cases of 
hypothyroidism and over 80% of hyperthyroidism were 
mild and probably did not need therapy. On the other 
hand, results of already treated patients were far from 
satisfactory because only in 68.8% of subjects were the 
expected appropriate values of TSH achieved. In this 
group, only 73% of 41persons on antithyroid drugs and 
61% of 145 on levothyroxine medication were euthyroid 
by laboratory criteria. 
Thyroid autoantibodies
For logistical and financial reasons, we measured 
TPOAb only in 1,594 respondents i.e. about one third 
of the cohort. TPOAb levels were distributed between 
4.2 and 9,995 U/L. Positive laboratory marker of thyroid 
autoimmunity i.e. TPOAb > 20 U/L was present in 17.4% 
of subjects from the whole cohort. Prevalence of TPOAb 
positivity was higher in females than in males (26.6% 
v.15.5%). Thyroid hormones were not available in all 
these subjects. Data of the whole cohort is presented 
in Figure 4 and Table V.
No significant differences in TPOAb values between 
age groups of elderly subjects were found. In addition, 
no statistically significant differences were found in the 
prevalence of TPOAb positivity between the younger 
reference group aged 55–59 years, and the population 
over 65 years (26.9% v. 23.6%). 
Among 1,542 subjects with known concentrations of both 
TPOAb and thyroid function, 1,110 were euthyroid (72%), 
317 hypothyroid (20.6%), and 115 hyperthyroid (7.4%). Posi-
tive results of TPOAb (i.e. exceeding 20 U/L) were unevenly 
distributed between subgroups with different levels of thy-
roid function. Prevalence of positive TPOAb results was sig-
nificantly higher in subjects with both thyroid dysfunctions 
Table IV. Thyroid function in relation to age
Table IV. Czynność tarczycy w zależności od wieku
Age group/years Hypothyroidism Hyperthyroidism Euthyroidism Number
55–59 7.65 1.82 90.52 549
65–69 6.94 2.54 90.52 592
70–74 8.04 3.72 88.24 591
75–79 7.88 2.13 89.98 673
80–84 8.47 1.84 89.69 602
85–89 7.29 3.73 88.98 590
≥ 90 9.7 4.85 85.85 495
All 7.95 2.94 89.11 4,051
Figure 4. Distribution of TPOAb values in the whole study group 
(n = 1,594)
Rycina 4. Rozkład stężeń TPOAb w grupie badanej (n= 1594)
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than in the euthyroid group (p < 0.05) and was highest in 
those with hypothyroidism (Table VI). 
There was a tendency towards a greater prevalence 
of TPOAb positivity in treated subjects compared to 
untreated ones with a comparable level of thyroid 
function (Tab VII). 
Discussion
Results presented in this paper represent a crossover 
study of a large randomly chosen cohort of ageing 
people from an unselected population. The strength 
of this study is the recruitment of a large number of 
elderly people from several urban and rural regions of 
the country, on the basis of population listing. The rural 
population was underrepresented, comprising only 5% 
of the cohort. Subjects included were recruited from an 
epidemiological survey and not from clinical practice. 
This population which included more than 4,000 aging 
subjects and was representative for elderly people. 
There were some limitations of this study. Assess-
ment of thyroid function was based solely on the results 
of the hormonal measurements. The study protocol was 
strict, so data collected in the questionnaires did not 
precisely inform beyond the patient’s past history and 
family background. No information on thyroid size, 
morphology or previous treatments, with the excep-
tion of thyreoidectomy, was available. Collected data 
contained information about presently used thyroid 
medications and iodine containing medications. There 
was little data concerning coexisting pathologies. 
We are conscious that there is doubt in diagnosing 
thyroid dysfunction on the basis of a single TSH meas-
urement only, without the analysis of all clinical data. It 
is obvious that TSH concentrations may be influenced 
by numerous factors, among them medications and 
chronic or acute extra thyroidal diseases. At the time of 
sampling, some participants might have had tempo-
rarily abnormal TSH. These factors may cause discrete 
variations of the results of hormonal measurements. 
Therefore, our data on the prevalence of thyroid dys-
functions may be slightly overestimated, because of the 
Table V. TPOAb concentrations of elderly subjects with known thyroid function: mean and median values and TPOAb 
positivity in age groups (n = 1,542)
Tabela V. Stężenia TPOAb w grupach wiekowych u osób z określoną czynnością tarczycy wartości średnie , mediany i częstość 
występowania podwyższonych stężeń (n = 1542)
TPOAb concentration IU/L
Age group/years Median Mean Range % elevated
55–59 10.0 180.6 6–2,085.4 26.9
65–69 9.8 168.6 4.7–3,032.8 24.6
70–74 10.25 196.1 6.1–2,931.9 25.9
75–79 10.4 127.0 5.2–2,032 25.3
80–84 10.3 140.4 6.0–2,701.8 21.5
85–89 10.4 147.4 4.2–9,995.4 20.8
≥ 90 10.7 117.2 5.9–2,461.3 23.0
All 10.3 150.2 4.2–9,995.4 23.9
Table VI. The distribution of elevated TPOAb in subgroups 
with different levels of thyroid function (n = 1,542) 
Table VI. Występowanie podwyższonego stężenia TPOAb 
w zależności od stanu czynnościowego tarczycy (n = 1542)
TSH range  
[mIU/mL]
< 0.2 0.2–5.4 > 4.5
n 115 1110 317
TPOAb > 20 
U/L 
% 23.4 16.6 50.2
n 27 184 159
Table VII. Elevated levels of TPOAb in treated (T) and 
untreated (NT) subjects with different thyroid function 
Tabela VII. Podwyższone stężenia TPOAb u osób leczonych 
(T) i nie leczonych (NT) z różnym stanem czynnościowym 
tarczycy
TSH 
range 
[mIU/L]
< 0.2 0.2–4.5 > 4.5 All
NT T NT T NT T NT T
TPOAb 
> 20 
IU/L %
20.6 43.7 16.05 32.4 20.6 43.7 22.5 46.8
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lack of precise clinical data analysis in individual cases. 
On the other hand, in our present study the reference 
range of TSH was wide, so this markedly diminished 
the possibility of misclassification of thyroid function.
Mean and median values of TSH in this project were 
higher than those published in data concerning selected 
American, Italian and Brazilian populations free of thy-
roid disease [4, 11–15]. These results are barely compa-
rable with our cohort which was randomly chosen from 
unselected lists. Our study revealed gender differences 
in TSH and fT4 values — both were significantly higher 
in women than in male subjects. 
The upper limit of normal TSH levels is a matter 
of debate [16–19]. Some American endocrinologists 
have suggested that the upper level of the normal 
reference range should be changed, because in over 
90% of healthy Americans, TSH levels do not exceed 
2.5 mIU/L. This data may not apply to non-American 
populations. This opinion does not find wide support 
among endocrinologists, especially in Europe, because 
differences in environmental and ethnic factors, and as 
well as iodine sufficiency, may have a strong impacts 
on thyroid function. The debate on this subject is still 
ongoing. [20–22]. It must be stressed that any lowering 
of the upper range of reference values would result 
in a remarkable increase in the diagnosis of subclini-
cal hypothyroidism [18]. In addition, epidemiological 
data from the US suggests that the upper level of the 
reference range of TSH for an older population should 
be increased with advancing age [14]. On the contrary, 
reports from European iodine deficient regions have 
revealed a tendency of TSH to decrease with ageing, 
resulting probably from the growing incidence of nodu-
lar goitre and thyroid autonomy [4, 11]. 
In a non selected Polish population, presented in this 
paper, TSH concentrations were as follows: arithmeti-
cal mean 2.55 mIU/L, median 1.6 mIU/L. In this cohort, 
26% of the results exceeded 2.5 mIU/L, which had been 
suggested as the upper limit of normal [23]. There have 
been no previous large population findings regarding 
thyroid epidemiology in Poland, with the exception of a 
post-Chernobyl study which recruited a much younger 
population exposed to environmental irradiation from 
that nuclear accident. 
Our study did not reveal a tendency of TSH to 
change with increasing age. Mean TSH and fT4 val-
ues were comparable in the whole population over 
65 years and the younger reference group as well as 
within the age subgroups of elderly participants. It has 
to be stressed that this study was cross-sectional and 
concerned an unselected population; a longitudinal 
project might allow a better estimation of the trends 
of changes in hormonal levels with increasing age. 
Divergent results were obtained in epidemiological 
studies. Previous data had shown a tendency to both 
a decrease and an increase of TSH with ageing. Data on 
this subject is discordant [13, 24–26].
Prospective studies have revealed that over the 
years, a slightly abnormal TSH value may remain on 
the same level or return to normal but in some sub-
jects abnormalities may progress to more advanced 
dysfunctions [27–29]. Some prospective observations 
have revealed the progression of subclinical to overt 
hypothyroidism in 17–40% of old age subjects [7, 40]. 
Higher TSH and/or TPOAb positivity predict progres-
sion from subclinical to overt hypothyroidism [26]. 
Some recent reports have shown that implementation 
of salt fortification may influence the epidemiology of 
thyroid diseases [7].
The criteria used in our study resulted in defining 
close to 90% of the elderly participants as euthyroid, 
nearly 3% as hyperthyroid, and 8% as hypothyroid. 
No significant differences in the distribution of thyroid 
dysfunctions were found in the population aged over 65 
years old, with the exception of the very oldest, where 
advanced ‘laboratory’ hypo- and hyperthyroidism were 
more prevalent. 
It would be very difficult to compare our data on 
the epidemiology of thyroid dysfunctions in the elderly 
with other studies. There were differences in the meth-
ods of inclusion of participants to population studies. 
There were ethnic differences and different conditions 
of iodine sufficiency. Previously described groups 
included volunteers, outpatients of GP practices, and 
populations randomised for epidemiological projects. 
Methods used and the quality of TSH measurement as 
well as criteria of normal values vary widely from study 
to study. This results in a diversity of laboratory criteria 
of thyroid dysfunction and consecutive estimation of 
incidence of hyperthyroidism and hypothyroidism 
[3, 15, 30, 31]. These facts strongly influence our under-
standing of the epidemiology of thyroid dysfunctions. 
Data concerning the epidemiology of thyroid dis-
eases is scarce. No relations concerning an ageing of 
the Polish population were available. Over the past 
decade, several papers have been published reporting 
an increasing prevalence of thyroid dysfunctions in 
Europe. In inhabitants of the Tayside region of Scotland, 
the incidence and prevalence of both hypothyroidism 
and hyperthyroidism in people of both sexes increased 
over a ten year period [32, 33].
It is not clear why the incidence and prevalence of 
thyroid disorders has a tendency to increase. It is obvi-
ous that this is in part the result of performing many 
more thyroid tests and of their greater sensitivity. Some 
recent data suggests an influence of salt fortification on 
the epidemiology of thyroid dysfunctions [7]. As the 
autoimmune process is the leading cause of endog-
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enous thyroid diseases, this growing number of thyroid 
dysfunctions might be the effect of autoimmunity [34].
Previous publications have suggested an increasing 
prevalence of thyroid dysfunctions with advancing age. 
The age span in some studies was greater than in this 
study, from relatively young to old age. The range of 
age presented in our paper involved only ageing people, 
so our observations cannot be simply compared to oth-
ers. We found a tendency towards more advanced and 
more frequent thyroid dysfunctions in the very oldest; 
in this age group, thyroid medications were prescribed 
less frequently. Symptomatology of thyroid disorders in 
very old people can be masked by the process of ageing 
and coexistent diseases, so the possibility of the presence 
of thyroid disease in these patients may be less obvious 
to some general practitioners [35].
Our project included an assessment of the preva-
lence of autoimmune thyroid disease in an elderly 
population on the basis of the occurrence of antithyroid 
peroxidase antibodies. Tests for TPOAb were performed 
in nearly 1,600 subjects. 
Overall, the 17.4% incidence of TPOAb positivity 
and increased prevalence in women in our cohort is 
relatively high, but it is comparable to some previous 
data. According to the earlier papers, autoimmune 
thyroid disease affects about 2% of the population, but 
antithyroid antibodies may be present in up to 20% [3, 
14, 36, 37].
As might be expected, TPOAb positivity was higher 
in persons with thyroid dysfunctions (over 40%), par-
ticularly in hypothyroid subjects (52%). Such results 
suggest that autoimmunity to thyroid antigens plays an 
important role in the aetiology of thyroid dysfunction, 
especially thyroid failure in this elderly population. 
The distribution of elevated TPOAb within the age 
subgroups was similar. We are fully conscious that our 
study was crossover not longitudinal, but our data 
did not support theories about the changing activity 
of autoimmune processes during ageing in humans. 
Marriotti et al. have shown an age dependent increase 
of incidence of thyroid antibodies in a population 
between 7 and 85 years of age. The prevalence in 
70–85 years old was significantly greater than in those 
aged below 50 years, but at the same time in a small 
group of 34 healthy centenarians aged 100–106 years, 
the occurrence of thyroid antibodies was similar to that 
in subjects less than 50 years old [38]. The observations 
of Roos et al. have revealed an increased prevalence 
of thyroid antibodies with age, particularly in women 
aged over 60 [37].
In the presented material, within three groups with 
different thyroid functions, a tendency was found to 
a higher prevalence of TPOAb positivity in treated than 
in untreated responders. This observation includes 
subjects who were successfully treated and euthyroid. 
One might speculate that subjects with higher levels 
of antibodies might have had more advanced, overt 
clinical dysfunction so their diagnosis and treatment 
took place early. There is no data suggesting that 
antithyroid drugs and levothyroxine might stimulate 
thyroid autoimmunity. On the contrary, there is some 
data suggesting their suppressive action on antithyroid 
antibodies. It is worth mentioning that in some former 
experimental and clinical studies, methimazole was 
found to have some immunosuppressive action and 
in some observations treatment with levothyroxine 
resulted in a decrease of antithyroid auto antibodies. 
For understandable reasons, we have no data on pre-
treatment thyroid antibodies in the group which is on 
thyroid medications.
Nearly 60% of subjects with thyroid dysfunction 
were not treated; the majority presented with subclini-
cal forms of hypo- or hyperfunction. It is to be stressed 
that until now there are no arguments speaking for 
the need and benefits from treatment of mild thyroid 
dysfunction, especially of hypothyroidism. Although 
treatment of mild thyroid failure with thyroid hormones 
results in the improvement of cardiovascular disease 
risk factors, there are no proven benefits resulting in 
longer survival. However, positive changes in quality 
of life have been achieved in some trials [39].
In addition, the decision about starting treatment 
must be considered cautiously. Longitudinal observa-
tions revealed that slightly abnormal TSH values may in 
time return to normal values, may remain on the same 
level, or progress to a more advanced abnormality [40]. 
However, the results of a prospective 10-year study 
of the population consisting of nearly 1,200 subjects 
over 60 years of age have shown that a single result of 
low serum thyrotropin (< 0,5 mIU/L) is associated with 
increased risk of all causes mortality, mainly from car-
diovascular system diseases by 2.2 to 3.3 in consecutive 
years. Best curves of survival were recorded in a cohort 
with TSH > 5 mIU/L [41].
Some reports have pointed to an increased risk of 
aortic atherosclerosis, myocardial infarction and heart 
failure in mildly hypothyroid patients, having TSH 
> 4mIU/L and normal fT4 [42, 43].
Meta-analysis published by Razvi et al. including 
over 27,000 unselected community dwelling subjects, 
observed for at least ten years, disclosed that subclinical 
hypothyroidism negatively influences cardiovascular 
risk in individuals < 65 years old, but not in older 
ones. [43] 
New data appears to suggest that higher TSH values 
and lower free thyroxin levels in ageing people might 
favour longer life [44, 45]. This observation concerned 
selected families known for longevity and also some 
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unselected populations described in published papers 
[46]. It is difficult to estimate the importance of these 
relations, because the criteria of classification of thyroid 
function parameters and characteristics of populations 
in these papers were different. [11, 43, 47, 48]
In older males, higher free thyroxin levels seem to 
be a risk factor of frailty and morbidity [49]. 
Our study revealed that among subjects with overt 
thyroid dysfunctions, the most advanced abnormalities 
were in the very oldest. This finding reminds us of the 
necessity of thorough clinical analysis, including the 
possibility of thyroid disease in ageing people, because 
in them the symptomatology of thyroid dysfunction 
can be misinterpreted as a result of ageing. It concerns 
such findings as decreasing intellectual functions, de-
terioration of activity or their general condition, and 
cardiovascular instability. It is generally known that 
both thyroid failure and hyperactivity may negatively 
influence the risk of cardiovascular diseasess, and their 
correction may result in improvement of the course of 
coexisting diseases. 
Our paper presents a review of laboratory param-
eters of thyroid function status in a large ageing unse-
lected population. Subjects with known, past or present, 
thyroid disease and positive family history of thyroid 
disease and TPOAb positive patients were not excluded 
from the cohort. It is clear that our results of hormonal 
measurements cannot serve as reference values, because 
they were assessed in an unselected population.
It has to be stressed that among the respondents 
treated for thyroid dysfunctions, only about 60% were 
euthyroid. It is possible that TSH levels might not exactly 
indicate their present thyreometabolic status, because 
some of them might have started treatment recently 
before blood sampling. Nevertheless, our observations 
confirm facts known from previous papers from differ-
ent countries, that a large part of a treated population 
does not achieve normal TSH levels. [3, 50, 51].
The practical conclusion is that thyroid therapy in 
the aged should be carefully monitored in order to pre-
scribe adequate dosing of medicine and avoid potential 
complications of inappropriate dosing. It is particularly 
important in elderly subjects, in whom dysthyroid sta-
tus can increase cardiovascular risk.
Conclusions 
1. A cross-sectional survey of a non selected elderly 
population did not reveal differences of TSH con-
centrations related to age.
2. Thyroid dysfunctions occur in over 10% of the elderly 
Polish population. 
 3. The prevalence of thyroid antibodies positivity in an 
elderly population does not change with age.
4. Only about a third of the elderly subjects treated for 
thyroid dysfunction achieved normal TSH levels. 
Final remarks 
Thyroid disease in elderly people, especially the very 
oldest, may be under-diagnosed.
Regular monitoring of elderly patients on thyroid 
medications is important.
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